{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:40:29Z","timestamp":1793914829379,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"High-level Talent Research Project of Shihezi University","award":["RCZK202456"],"award-info":[{"award-number":["RCZK202456"]}]},{"name":"the Talent Program \"Tianchi Talent (Young Docter)\" in Xinjiang Uygur Autonomous Region"},{"name":"the Key R&D Program Project of Hebei Province","award":["21322912D"],"award-info":[{"award-number":["21322912D"]}]},{"name":"the Xinjiang Uygur Autonomous Region Corps Key Research and Development Program","award":["2023AB009-03"],"award-info":[{"award-number":["2023AB009-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"DOI":"10.1186\/s12917-025-04842-5","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T01:22:00Z","timestamp":1748395320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["PRRSV GP4 subunit vaccine combined with adenovirus heterologous prime-boost immunization strategy induced a significant immune response in mice"],"prefix":"10.1186","volume":"21","author":[{"given":"Honghuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aodi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongchen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangfu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"1\u20134","key":"4842_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0378-1135(96)01327-2","volume":"55","author":"TW Molitor","year":"1997","unstructured":"Molitor TW, Bautista EM, Choi CS. Immunity to PRRSV: double-edged sword. Vet Microbiol. 1997;55(1\u20134):265\u201376.","journal-title":"Vet Microbiol"},{"issue":"3","key":"4842_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/01652176.1991.9694297","volume":"13","author":"C Terpstra","year":"1991","unstructured":"Terpstra C, Wensvoort G, Pol JM. Experimental reproduction of Porcine epidemic abortion and respiratory syndrome (mystery swine disease) by infection with Lelystad virus: Koch\u2019s postulates fulfilled. Vet Q. 1991;13(3):131\u20136.","journal-title":"Vet Q"},{"issue":"2","key":"4842_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/104063879200400201","volume":"4","author":"JE Collins","year":"1992","unstructured":"Collins JE, Benfield DA, Christianson WT, Harris L, Hennings JC, Shaw DP, et al. Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs. J Vet Diagn Invest. 1992;4(2):117\u201326.","journal-title":"J Vet Diagn Invest"},{"key":"4842_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-animal-022114-111025","volume":"4","author":"JK Lunney","year":"2016","unstructured":"Lunney JK, Fang Y, Ladinig A, Chen N, Li Y, Rowland B, et al. Porcine reproductive and respiratory syndrome virus (PRRSV): pathogenesis and interaction with the immune system. Annu Rev Anim Biosci. 2016;4:129\u201354.","journal-title":"Annu Rev Anim Biosci"},{"issue":"3\u20134","key":"4842_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.vetmic.2010.05.011","volume":"146","author":"B Li","year":"2010","unstructured":"Li B, Fang L, Liu S, Zhao F, Jiang Y, He K, et al. The genomic diversity of Chinese Porcine reproductive and respiratory syndrome virus isolates from 1996 to 2009. Vet Microbiol. 2010;146(3\u20134):226\u201337.","journal-title":"Vet Microbiol"},{"issue":"1","key":"4842_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12985-017-0910-6","volume":"15","author":"Z Guo","year":"2018","unstructured":"Guo Z, Chen XX, Li R, Qiao S, Zhang G. The prevalent status and genetic diversity of Porcine reproductive and respiratory syndrome virus in China: a molecular epidemiological perspective. Virol J. 2018;15(1):2.","journal-title":"Virol J"},{"issue":"12","key":"4842_CR7","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3390\/vaccines12121387","volume":"12","author":"H Wang","year":"2024","unstructured":"Wang H, Feng W. Current status of Porcine reproductive and respiratory syndrome vaccines. Vaccines (Basel). 2024;12(12):1387.","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"4842_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3390\/vetsci10080491","volume":"10","author":"H Zhang","year":"2023","unstructured":"Zhang H, Luo Q, He Y, Zheng Y, Sha H, Li G, et al. Research progress on the development of Porcine reproductive and respiratory syndrome vaccines. Vet Sci. 2023;10(8):491.","journal-title":"Vet Sci"},{"issue":"33","key":"4842_CR9","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1016\/j.vaccine.2015.06.092","volume":"33","author":"GJ Renukaradhya","year":"2015","unstructured":"Renukaradhya GJ, Meng XJ, Calvert JG, Roof M, Lager KM. Live Porcine reproductive and respiratory syndrome virus vaccines: current status and future direction. Vaccine. 2015;33(33):4069\u201380.","journal-title":"Vaccine"},{"issue":"1","key":"4842_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12985-016-0586-3","volume":"13","author":"X Wang","year":"2016","unstructured":"Wang X, Wang Z, Xu H, Biao X, Yang Z. A single amino acid substitution alter antigenicity of glycosylated protein 4 of HP-PRRSV. Virol J. 2016;13(1):129.","journal-title":"Virol J"},{"issue":"1","key":"4842_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/vetsci6010009","volume":"6","author":"AMM Stoian","year":"2019","unstructured":"Stoian AMM, Rowland RRR. Challenges for Porcine reproductive and respiratory syndrome (PRRS) vaccine design: reviewing virus glycoprotein interactions with CD163 and targets of virus neutralization. Vet Sci. 2019;6(1):9.","journal-title":"Vet Sci"},{"key":"4842_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.vetmic.2018.08.027","volume":"224","author":"W Chen","year":"2018","unstructured":"Chen W, Cui J, Wang J, Sun Y, Ji C, Song R, et al. Phages bearing specific peptides with affinity for Porcine reproductive and respiratory syndrome virus GP4 protein prevent cell penetration of the virus. Vet Microbiol. 2018;224:43\u20139.","journal-title":"Vet Microbiol"},{"issue":"1\u20132","key":"4842_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.virusres.2010.08.026","volume":"154","author":"S Costers","year":"2010","unstructured":"Costers S, Vanhee M, Van Breedam W, Van Doorsselaere J, Geldhof M, Nauwynck HJ. GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution. Virus Res. 2010;154(1\u20132):104\u201313.","journal-title":"Virus Res"},{"issue":"3","key":"4842_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00705-009-0582-7","volume":"155","author":"S Costers","year":"2010","unstructured":"Costers S, Lefebvre DJ, Van Doorsselaere J, Vanhee M, Delputte PL, Nauwynck HJ. GP4 of Porcine reproductive and respiratory syndrome virus contains a neutralizing epitope that is susceptible to Immunoselection in vitro. Arch Virol. 2010;155(3):371\u20138.","journal-title":"Arch Virol"},{"issue":"3","key":"4842_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/21655979.2016.1191707","volume":"7","author":"M Wang","year":"2016","unstructured":"Wang M, Jiang S, Wang Y. Recent advances in the production of Recombinant subunit vaccines in Pichia pastoris. Bioengineered. 2016;7(3):155\u201365.","journal-title":"Bioengineered"},{"key":"4842_CR16","doi-asserted-by":"publisher","first-page":"1024720","DOI":"10.3389\/fvets.2022.1024720","volume":"9","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Li Z, Li H, Yang S, Ren F, Bian T, et al. The economic impact of Porcine reproductive and respiratory syndrome outbreak in four Chinese farms: based on cost and revenue analysis. Front Vet Sci. 2022;9:1024720.","journal-title":"Front Vet Sci"},{"key":"4842_CR17","doi-asserted-by":"publisher","first-page":"109168","DOI":"10.1016\/j.vetmic.2021.109168","volume":"260","author":"I Ruedas-Torres","year":"2021","unstructured":"Ruedas-Torres I, Rodr\u00edguez-G\u00f3mez IM, S\u00e1nchez-Carvajal JM, Larenas-Mu\u00f1oz F, Pallar\u00e9s FJ, Carrasco L, et al. The Jigsaw of PRRSV virulence. Vet Microbiol. 2021;260:109168.","journal-title":"Vet Microbiol"},{"issue":"6","key":"4842_CR18","doi-asserted-by":"publisher","first-page":"e66645","DOI":"10.1371\/journal.pone.0066645","volume":"8","author":"L Zhou","year":"2013","unstructured":"Zhou L, Ni YY, Pi\u00f1eyro P, Cossaboom CM, Subramaniam S, Sanford BJ, et al. Broadening the heterologous cross-neutralizing antibody inducing ability of Porcine reproductive and respiratory syndrome virus by breeding the GP4 or M genes. PLoS ONE. 2013;8(6):e66645.","journal-title":"PLoS ONE"},{"issue":"4","key":"4842_CR19","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00425-017-2836-z","volume":"247","author":"CH An","year":"2018","unstructured":"An CH, Nazki S, Park SC, Jeong YJ, Lee JH, Park SJ, et al. Plant synthetic GP4 and GP5 proteins from Porcine reproductive and respiratory syndrome virus elicit immune responses in pigs. Planta. 2018;247(4):973\u201385.","journal-title":"Planta"},{"issue":"3","key":"4842_CR20","doi-asserted-by":"publisher","first-page":"e91386","DOI":"10.1371\/journal.pone.0091386","volume":"9","author":"R Piron","year":"2014","unstructured":"Piron R, De Koker S, De Paepe A, Goossens J, Grooten J, Nauwynck H, et al. Boosting in planta production of antigens derived from the Porcine reproductive and respiratory syndrome virus (PRRSV) and subsequent evaluation of their immunogenicity. PLoS ONE. 2014;9(3):e91386.","journal-title":"PLoS ONE"},{"issue":"1","key":"4842_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/acsnano.4c12212","volume":"19","author":"Y Sun","year":"2025","unstructured":"Sun Y, Gao Y, Su T, Zhang L, Zhou H, Zhang J, et al. Nanoparticle vaccine triggers interferon-gamma production and confers protective immunity against Porcine reproductive and respiratory syndrome virus. ACS Nano. 2025;19(1):852\u201370.","journal-title":"ACS Nano"},{"key":"4842_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41541-017-0006-8","volume":"2","author":"X Huang","year":"2017","unstructured":"Huang X, Wang X, Zhang J, Xia N, Zhao Q. Escherichia coli-derived virus-like particles in vaccine development. NPJ Vaccines. 2017;2:3.","journal-title":"NPJ Vaccines"},{"key":"4842_CR23","doi-asserted-by":"publisher","first-page":"108417","DOI":"10.1016\/j.biotechadv.2024.108417","volume":"75","author":"R Jiang","year":"2024","unstructured":"Jiang R, Yuan S, Zhou Y, Wei Y, Li F, Wang M, et al. Strategies to overcome the challenges of low or no expression of heterologous proteins in Escherichia coli. Biotechnol Adv. 2024;75:108417.","journal-title":"Biotechnol Adv"},{"issue":"5","key":"4842_CR24","doi-asserted-by":"publisher","first-page":"e64893","DOI":"10.1371\/journal.pone.0064893","volume":"8","author":"GP Singh","year":"2013","unstructured":"Singh GP, Dash D. Electrostatic mis-interactions cause overexpression toxicity of proteins in E. coli. PLoS ONE. 2013;8(5):e64893.","journal-title":"PLoS ONE"},{"issue":"3","key":"4842_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/156652307780859062","volume":"7","author":"SK Campos","year":"2007","unstructured":"Campos SK, Barry MA. Current advances and future challenges in adenoviral vector biology and targeting. Curr Gene Ther. 2007;7(3):189\u2013204.","journal-title":"Curr Gene Ther"},{"issue":"1","key":"4842_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12896-015-0121-4","volume":"15","author":"H Chen","year":"2015","unstructured":"Chen H, Wang D, Xia R, Mao Q, Xia H. A novel adenoviral vector carrying an all-in-one Tet-On system with an autoregulatory loop for tight, inducible transgene expression. BMC Biotechnol. 2015;15(1):4.","journal-title":"BMC Biotechnol"},{"issue":"1","key":"4842_CR27","doi-asserted-by":"publisher","first-page":"8189","DOI":"10.1038\/s41598-023-35328-9","volume":"13","author":"JY Kim","year":"2023","unstructured":"Kim JY, Jeon K, Hong JJ, Park SI, Cho H, Park HJ, et al. Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV. Sci Rep. 2023;13(1):8189.","journal-title":"Sci Rep"},{"key":"4842_CR28","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3389\/fimmu.2020.01408","volume":"11","author":"S Singh","year":"2020","unstructured":"Singh S, Yanow SK, Agrawal B. Editorial: heterologous immunity: implications and applications in vaccines and immunotherapies. Front Immunol. 2020;11:1408.","journal-title":"Front Immunol"},{"issue":"8","key":"4842_CR29","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/14760584.2019.1640117","volume":"18","author":"JL Excler","year":"2019","unstructured":"Excler JL, Kim JH. Novel prime-boost vaccine strategies against HIV-1. Expert Rev Vaccines. 2019;18(8):765\u201379.","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"4842_CR30","doi-asserted-by":"publisher","first-page":"112599","DOI":"10.1016\/j.celrep.2023.112599","volume":"42","author":"RA Ramirez-Valdez","year":"2023","unstructured":"Ramirez-Valdez RA, Baharom F, Khalilnezhad A, Fussell SC, Hermans DJ, Schrager AM, et al. Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression. Cell Rep. 2023;42(6):112599.","journal-title":"Cell Rep"},{"key":"4842_CR31","doi-asserted-by":"publisher","first-page":"106328","DOI":"10.1016\/j.micpath.2023.106328","volume":"183","author":"H Zhang","year":"2023","unstructured":"Zhang H, Ren J, Li J, Zhai C, Mao F, Yang S, et al. Comparison of heterologous prime-boost immunization strategies with DNA and Recombinant vaccinia virus co-expressing GP3 and GP5 of European type Porcine reproductive and respiratory syndrome virus in pigs. Microb Pathog. 2023;183:106328.","journal-title":"Microb Pathog"},{"issue":"4","key":"4842_CR32","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.vaccine.2021.12.024","volume":"40","author":"NH Chung","year":"2022","unstructured":"Chung NH, Chen YC, Yang SJ, Lin YC, Dou HY, Hui-Ching Wang L, et al. Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered Spike protein. Vaccine. 2022;40(4):574\u201386.","journal-title":"Vaccine"},{"issue":"1","key":"4842_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1086\/653121","volume":"202","author":"S Bodhankar","year":"2010","unstructured":"Bodhankar S, Sun X, Woolard MD, Simecka JW. Interferon gamma and Interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against mycoplasma respiratory disease. J Infect Dis. 2010;202(1):39\u201351.","journal-title":"J Infect Dis"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-04842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-025-04842-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-04842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T01:22:02Z","timestamp":1748395322000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-025-04842-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4842"],"URL":"https:\/\/doi.org\/10.1186\/s12917-025-04842-5","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments in this study were conducted under the guidelines of the Shihezi University Institutional Animal Care and Use Committee and approved by the Animal Ethics Committee of Shihezi University (No. 2023\u2009\u2212\u2009246).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"379"}}